Reply: Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting.

Subjects

Subjects :

Anti-Inflammatory Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Humans
Cardiovascular Diseases
Diabetes Mellitus

Details

Language :

English

ISSN :

1558-3597

Volume :

72

Issue :

12

Database :

MEDLINE

Journal :

Journal of the American College of Cardiology

Publication Type :

Editorial & Opinion

Accession number :

30213342

Full Text :

https://doi.org/10.1016/j.jacc.2018.07.021